vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $14.6M, roughly 1.3× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs 58.9%, a 5.3% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 24.3%). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

BLFS vs IDR — Head-to-Head

Bigger by revenue
BLFS
BLFS
1.3× larger
BLFS
$18.8M
$14.6M
IDR
Growing faster (revenue YoY)
IDR
IDR
+67.7% gap
IDR
92.0%
24.3%
BLFS
Higher net margin
IDR
IDR
5.3% more per $
IDR
64.3%
58.9%
BLFS
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
IDR
IDR
Revenue
$18.8M
$14.6M
Net Profit
$11.1M
$9.4M
Gross Margin
68.5%
Operating Margin
7.2%
62.4%
Net Margin
58.9%
64.3%
Revenue YoY
24.3%
92.0%
Net Profit YoY
-11.1%
220.6%
EPS (diluted)
$0.23
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
IDR
IDR
Q4 25
$18.8M
$14.6M
Q3 25
$28.1M
$11.1M
Q2 25
$25.4M
$9.5M
Q1 25
$23.9M
$7.3M
Q4 24
$15.1M
$7.6M
Q3 24
$21.4M
$6.2M
Q2 24
$19.7M
$6.1M
Q1 24
$18.4M
$5.9M
Net Profit
BLFS
BLFS
IDR
IDR
Q4 25
$11.1M
$9.4M
Q3 25
$621.0K
$3.0M
Q2 25
$-15.8M
$2.8M
Q1 25
$-448.0K
$1.6M
Q4 24
$12.5M
$2.9M
Q3 24
$-1.7M
$1.6M
Q2 24
$-20.7M
$2.2M
Q1 24
$-10.2M
$2.2M
Gross Margin
BLFS
BLFS
IDR
IDR
Q4 25
68.5%
Q3 25
63.6%
Q2 25
57.8%
Q1 25
50.8%
Q4 24
53.3%
Q3 24
48.7%
Q2 24
50.2%
Q1 24
48.1%
Operating Margin
BLFS
BLFS
IDR
IDR
Q4 25
7.2%
62.4%
Q3 25
-0.3%
23.4%
Q2 25
-65.5%
26.6%
Q1 25
-5.1%
19.3%
Q4 24
3.6%
36.2%
Q3 24
-2.0%
23.4%
Q2 24
-6.6%
34.2%
Q1 24
-17.9%
36.3%
Net Margin
BLFS
BLFS
IDR
IDR
Q4 25
58.9%
64.3%
Q3 25
2.2%
26.8%
Q2 25
-62.3%
29.2%
Q1 25
-1.9%
22.1%
Q4 24
82.5%
38.5%
Q3 24
-8.0%
25.8%
Q2 24
-105.1%
35.2%
Q1 24
-55.4%
36.8%
EPS (diluted)
BLFS
BLFS
IDR
IDR
Q4 25
$0.23
$0.62
Q3 25
$0.01
$0.20
Q2 25
$-0.33
$0.20
Q1 25
$-0.01
$0.12
Q4 24
$0.27
$0.21
Q3 24
$-0.04
$0.12
Q2 24
$-0.45
$0.17
Q1 24
$-0.22
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
IDR
IDR
Cash + ST InvestmentsLiquidity on hand
$33.0M
Total DebtLower is stronger
$5.0M
$2.3M
Stockholders' EquityBook value
$371.9M
$108.2M
Total Assets
$405.9M
$116.2M
Debt / EquityLower = less leverage
0.01×
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
IDR
IDR
Q4 25
$33.0M
Q3 25
$29.5M
Q2 25
$31.9M
Q1 25
$66.9M
Q4 24
$91.5M
Q3 24
$24.0M
Q2 24
$22.0M
$6.3M
Q1 24
$29.7M
$5.3M
Total Debt
BLFS
BLFS
IDR
IDR
Q4 25
$5.0M
$2.3M
Q3 25
$7.5M
$3.0M
Q2 25
$10.1M
$3.3M
Q1 25
$12.9M
$3.7M
Q4 24
$15.9M
$1.7M
Q3 24
$20.1M
$2.9M
Q2 24
$21.1M
$2.7M
Q1 24
$24.3M
$3.3M
Stockholders' Equity
BLFS
BLFS
IDR
IDR
Q4 25
$371.9M
$108.2M
Q3 25
$353.7M
$74.3M
Q2 25
$347.2M
$49.3M
Q1 25
$352.6M
$39.8M
Q4 24
$348.9M
$37.7M
Q3 24
$325.5M
$33.1M
Q2 24
$321.4M
$25.4M
Q1 24
$333.4M
$21.6M
Total Assets
BLFS
BLFS
IDR
IDR
Q4 25
$405.9M
$116.2M
Q3 25
$392.1M
$83.1M
Q2 25
$387.2M
$57.7M
Q1 25
$395.1M
$48.1M
Q4 24
$399.5M
$44.0M
Q3 24
$381.7M
$40.8M
Q2 24
$375.0M
$32.2M
Q1 24
$401.6M
$28.7M
Debt / Equity
BLFS
BLFS
IDR
IDR
Q4 25
0.01×
0.02×
Q3 25
0.02×
0.04×
Q2 25
0.03×
0.07×
Q1 25
0.04×
0.09×
Q4 24
0.05×
0.05×
Q3 24
0.06×
0.09×
Q2 24
0.07×
0.11×
Q1 24
0.07×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
IDR
IDR
Operating Cash FlowLast quarter
$4.9M
$10.7M
Free Cash FlowOCF − Capex
$8.2M
FCF MarginFCF / Revenue
56.0%
Capex IntensityCapex / Revenue
17.7%
Cash ConversionOCF / Net Profit
0.44×
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
IDR
IDR
Q4 25
$4.9M
$10.7M
Q3 25
$6.1M
$2.4M
Q2 25
$7.4M
$3.5M
Q1 25
$1.7M
$2.4M
Q4 24
$1.6M
$3.2M
Q3 24
$4.8M
$2.5M
Q2 24
$6.5M
$2.6M
Q1 24
$-4.5M
$2.6M
Free Cash Flow
BLFS
BLFS
IDR
IDR
Q4 25
$8.2M
Q3 25
$709.8K
Q2 25
$2.5M
Q1 25
$1.0M
Q4 24
$2.1M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
$2.3M
FCF Margin
BLFS
BLFS
IDR
IDR
Q4 25
56.0%
Q3 25
6.4%
Q2 25
26.5%
Q1 25
13.8%
Q4 24
28.0%
Q3 24
30.4%
Q2 24
38.7%
Q1 24
38.3%
Capex Intensity
BLFS
BLFS
IDR
IDR
Q4 25
17.7%
Q3 25
15.3%
Q2 25
10.8%
Q1 25
19.4%
Q4 24
13.6%
Q3 24
9.8%
Q2 24
4.3%
Q1 24
5.5%
Cash Conversion
BLFS
BLFS
IDR
IDR
Q4 25
0.44×
1.15×
Q3 25
9.83×
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
0.13×
1.08×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons